Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02872467 · ClinicalTrials.gov registry record · Phase 1
Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology
A Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
NCT02872467 is a Phase 1 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 31 participants.
The verdict
NCT02872467, a Phase 1 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this research is to study the effects of nasal oxytocin administration on maternal behaviors that may be influenced by cocaine use during pregnancy. 32 mothers with prenatal use of cocaine during the current pregnancy will be studied at 3-6 months postpartum, when they will complete 3 study visits, a 2-week double-blind trial of twice daily nasal spray (oxytocin or placebo) and 4 telephone interviews. All information collected is confidential.
Interventions
- OTHER Placebo
- DRUG Syntocinon treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2016-05 |
| Est. Completion | 2023-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02872467
The ClinicalTrials.gov registry entry for NCT02872467 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02872467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02872467 about?
NCT02872467 is a clinical study titled "Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology". The purpose of this research is to study the effects of nasal oxytocin administration on maternal behaviors that may be influenced by cocaine use during pregnancy. 32 mothers with prenatal use of cocaine during the current pregnancy will be studied at 3-6 months postpartum, when they will complete 3...
What is the current status of trial NCT02872467?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2016-05. Estimated completion is 2023-03.
What interventions are being tested in trial NCT02872467?
The interventions under investigation include: Placebo (OTHER), Syntocinon treatment (DRUG).
Who is sponsoring clinical trial NCT02872467?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.